South Korea Head And Neck Cancer Therapeutics Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$30.6

Forecast, 2030 (US$M)

$75.6

CAGR, 2024 - 2030

13.8%

Report Coverage

South Korea

South Korea head and neck cancer therapeutics market, 2018-2030 (US$M)

Related Markets

Global Head And Neck Cancer Therapeutics Industry Outlook

North America Head And Neck Cancer Therapeutics Market Outlook

U.S. Head And Neck Cancer Therapeutics Market Outlook

Canada Head And Neck Cancer Therapeutics Market Outlook

Europe Head And Neck Cancer Therapeutics Market Outlook

Germany Head And Neck Cancer Therapeutics Market Outlook

France Head And Neck Cancer Therapeutics Market Outlook

Italy Head And Neck Cancer Therapeutics Market Outlook

Spain Head And Neck Cancer Therapeutics Market Outlook

Denmark Head And Neck Cancer Therapeutics Market Outlook

Sweden Head And Neck Cancer Therapeutics Market Outlook

Norway Head And Neck Cancer Therapeutics Market Outlook

UK Head And Neck Cancer Therapeutics Market Outlook

Asia Pacific Head And Neck Cancer Therapeutics Market Outlook

Japan Head And Neck Cancer Therapeutics Market Outlook

China Head And Neck Cancer Therapeutics Market Outlook

India Head And Neck Cancer Therapeutics Market Outlook

Australia Head And Neck Cancer Therapeutics Market Outlook

Thailand Head And Neck Cancer Therapeutics Market Outlook

Latin America Head And Neck Cancer Therapeutics Market Outlook

Mexico Head And Neck Cancer Therapeutics Market Outlook

Argentina Head And Neck Cancer Therapeutics Market Outlook

Brazil Head And Neck Cancer Therapeutics Market Outlook

MEA Head And Neck Cancer Therapeutics Market Outlook

South Africa Head And Neck Cancer Therapeutics Market Outlook

Saudi Arabia Head And Neck Cancer Therapeutics Market Outlook

UAE Head And Neck Cancer Therapeutics Market Outlook

Kuwait Head And Neck Cancer Therapeutics Market Outlook

South Korea head and neck cancer therapeutics market highlights

The South Korea head and neck cancer therapeutics market generated a revenue of USD 30.6 million in 2023 and is expected to reach USD 75.6 million by 2030.
The South Korea market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
In terms of segment, immunotherapy was the largest revenue generating type in 2023.
Immunotherapy is the most lucrative type segment registering the fastest growth during the forecast period.

Head and neck cancer therapeutics market data book summary

Market revenue in 2023	USD 30.6 million
Market revenue in 2030	USD 75.6 million
Growth rate	13.8% (CAGR from 2023 to 2030)
Largest segment	Immunotherapy
Fastest growing segment	Immunotherapy
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Chemotherapy, Immunotherapy, Targeted Therapy
Key market players worldwide	Eli Lilly and Co, Sanofi SA, Merck & Co Inc, Bristol-Myers Squibb Co, AstraZeneca PLC, Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd, Roche Holding AG ADR, Clinigen Group

Other key industry trends

In terms of revenue, South Korea accounted for 1.5% of the global head and neck cancer therapeutics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, Japan head and neck cancer therapeutics market is projected to lead the regional market in terms of revenue in 2030.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 178.0 million by 2030.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Head And Neck Cancer Therapeutics Market Scope

Head and neck cancer therapeutics market segmentation & scope

Type

Chemotherapy

Immunotherapy

Targeted Therapy

Route of Administration

Injectable

Oral

Distribution Channel

Retail & Specialty Pharmacies

Regions

Europe

Countries

U.S.

Canada

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Japan

China

India

Brazil

Mexico

UAE

Kuwait

Head And Neck Cancer Therapeutics Market Companies

Name	Profile	# Employees	HQ	Website

South Korea head and neck cancer therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to head and neck cancer therapeutics market will help companies and investors design strategic landscapes.

Immunotherapy was the largest segment with a revenue share of 60.13% in 2023. Horizon Databook has segmented the South Korea head and neck cancer therapeutics market based on chemotherapy, immunotherapy, targeted therapy covering the revenue growth of each sub-segment from 2018 to 2030.

The pharmaceutical market in South Korea is a growing and competitive industry. It is one of the largest markets in Asia and has been witnessing steady growth over the years. The country has a well-developed healthcare system and strongly emphasizes R&D, making it a lucrative market for pharmaceutical companies.

Increasing R&D investments by key pharmaceutical companies in South Korea are expected to create a lucrative environment for market growth. For instance, in October 2022, AstraZeneca announced that it will spend USD 630.0 million on R&D in South Korea over the next 5 years to improve access to healthcare. The rising prevalence of head and neck cancer also drives the market growth.

The lip & oral cavity and larynx cancer are the most common types of head and neck cancer in South Korea. Furthermore, key players have constantly been focusing on the launch of products and geographic expansion to diversify and expand their product portfolios.

Reasons to subscribe to South Korea head and neck cancer therapeutics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea head and neck cancer therapeutics market databook

Our clientele includes a mix of head and neck cancer therapeutics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea head and neck cancer therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea head and neck cancer therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.